JOANNA MARMARO: Open Payments
NPI 1104363142 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$740 in 33 payments from 21 companies in 2025. Trend: 2023 $313 · 2024 $334 · 2025 $740
Food & beverage: $740
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $210 |
| Janssen Biotech, Inc. | 3 | $55 |
| Geron Corporation | 2 | $47 |
| Novartis Pharmaceuticals Corporation | 2 | $43 |
| Genmab U.S., Inc. | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $28 |
| Aveo Pharmaceuticals, Inc. | 1 | $27 |
| Incyte Corporation | 1 | $27 |
| BeOne Medicines USA, Inc. | 1 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
Products named: IMFINZI, ENHERTU, EPKINLY, RYTELO, SCEMBLIX, RYBREVANT, PADCEV, OJJAARA.
Industry payments across TX — which companies pay providers there.
